Vulnerable Patients in Primary Care: Nurse Case Management and Self-management Support (V1SAGES)

December 1, 2014 updated by: Catherine Hudon, Université de Sherbrooke

Pragmatic Evaluation of Case Management and Self-management Support for Vulnerable People With Chronic Diseases in Primary Care

The purpose of this study is to implement a pragmatic intervention in four (4) family medicine groups(FMGs) in the region of Saguenay-Lac-Saint-Jean (Quebec, Canada)for patients with chronic diseases.

Study Overview

Status

Completed

Conditions

Detailed Description

Chronic diseases represent a major health burden worldwide. Some people with chronic diseases require a higher level of care due to personal characteristics that increase their vulnerability. For these patients, nurse effective case management in primary care are associated with positive outcomes. Moreover, self-management programs, such as the standford program developed by the School of Medicine at the University of Standford in California (USA), are also recognized for their benefits on patients with chronic diseases.

The aim of our project is to implement, within four (4) FMGs of the region of Saguenay-Lac-Saint-Jean , a practical intervention involving case management by a nurse to promote interdisciplinary person-centered monitoring and self-management support for highly vulnerable individuals with chronic diseases (diabetes, cardiovascular diseases, respiratory diseases, musculoskeletal diseases and/or chronic pain).

The objectives of our study : 1) To analyze the implementation of the intervention in the participating FMGs in order to determine how the various contexts have influenced the implementation and the observed effects; 2) To evaluate the proximal and intermediate effects of the intervention on patients; 3) To conduct an economic analysis of the effectiveness and cost-benefit of the intervention.

The analysis of the implementation will be conducted using realistic evaluation approaches and participatory practice within four categories of key players (FMG stakeholders, FMG/health center managers, patients and their families, health center partners or communities). The data will be obtained through individual or group interviews, literature reviews and documentation from the intervention undertaken. The evaluation of the effects in patients will be based on a pragmatic randomized experimental design before and after (six months) with delayed intervention in the control group. Economic analysis will include a cost-effectiveness analysis and a cost-benefit analysis.

Study Type

Interventional

Enrollment (Actual)

247

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Quebec
      • Alma, Quebec, Canada, G8B 5W3
        • Centre de santé et de services sociaux Lac-Saint-Jean-Est
      • Chicoutim, Quebec, Canada, G7H 5H6
        • Centre de sante et de services sociaux de Chicoutimi

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 80 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Patient of the participating FMGs
  • Aged between 25 and 80 years
  • Affected by chronic disease (diabetes, cardiovascular diseases, respiratory diseases, musculoskeletal diseases and/or chronic pain)
  • Identified as a frequent user of health services (by a health care provider or/and a software)

Exclusion Criteria:

  • Patient unable to provide consent
  • With cognitive impairment
  • With uncontrolled psychiatric illness
  • Patient with a prognostic of less than one years

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Nurse case management and self-management support
The first component of the intervention is the monitoring offered under the case management process. The second component of the intervention consists of group meetings (10-12 people) for self-management support in accordance with the stanford model. A sample of patients in each of the four FMGs (n = 126) will be recruited. These patients will receive the intervention for six months.

Case management: The intervention will focus on four main components: (1) A thorough evaluation of the patient's needs and resources; (2) Establishing and maintaining a patient-centered, individualized service plan (ISP); (3) Coordination of services among partners; and (4) Self-management support for patients and their families.

Self-management support: A standardized six-week program with interactive weekly group meetings led by two volunteer peer helpers (appointed trainers), who themselves have a chronic disease.

No Intervention: Control group
Patients in the control group (n = 121) will receive the usual care for six months and then the same intervention as the experimental group for the next five months (waiting list control group).

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in patient perception of personal self-efficacy at 6 months
Time Frame: 6 months
The patient capacity to self-management measured by the Self-Efficacy for Managing Chronic Disease instrument.
6 months
Change in patient perception of self-management practice at 6 months
Time Frame: 6 months
The patient capacity to manage their condition and their physical and psychological reaction measured by a subscale of the Health Education Impact Questionnaire (HEIQ).
6 months
Change in patient perception of health behaviours at 6 months
Time Frame: 6 months
Fruit and vegetable consumption, smoking status, alcohol consumption, healthy weight and physical activity.
6 months
Change in patient perception of activation at 6 month
Time Frame: 6 months
Patient knowledge, skills and self-confidence in self-management measured by the Patient Activation instrument.
6 months
Change in patient perception of psychological distress at 6 months
Time Frame: 6 months
Measured by the Psychological Distress instrument.
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in patient perception of empowerment at 6 months.
Time Frame: 6 months
Health education impact measured by the Health Education Impact Questionnaire (HEIQ).
6 months
Change in patient perception of quality of life at 6 months
Time Frame: 6 months
Measured by the 12-Item Short Form Health Survey
6 months
Change in use of health services at 6 months
Time Frame: 6 months
Measured by hospitalizations, emergency room visits and health services use(e.g., psychosocial services or specialized services related to the specific chronic disease.
6 months

Other Outcome Measures

Outcome Measure
Measure Description
Time Frame
Socioeconomic status
Time Frame: 2 weeks before the intervention
2 weeks before the intervention
Health literacy status
Time Frame: 2 weeks before the intervention
The degree to which individuals have the capacity to obtain, process and understand basic health information and services needed to make appropriate health decisions measured by the Newest Vital Sign.
2 weeks before the intervention
Mental health status
Time Frame: 2 weeks before the intervention
Measured by the Hospital Anxiety and Depression Scale.
2 weeks before the intervention

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Catherine Hudon, PhD, Université de Sherbrooke
  • Principal Investigator: Maud-Christine Chouinard, PhD, Université du Québec à Chicoutimi

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

November 1, 2012

Primary Completion (Actual)

June 1, 2014

Study Completion (Actual)

September 1, 2014

Study Registration Dates

First Submitted

October 25, 2012

First Submitted That Met QC Criteria

October 31, 2012

First Posted (Estimate)

November 1, 2012

Study Record Updates

Last Update Posted (Estimate)

December 3, 2014

Last Update Submitted That Met QC Criteria

December 1, 2014

Last Verified

December 1, 2014

More Information

Terms related to this study

Other Study ID Numbers

  • FRSQ-26758

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

product manufactured in and exported from the U.S.

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Chronic Diseases

Clinical Trials on Nurse case management and self-management support

3
Subscribe